CompanyIntelligence | Neurogen Corp.

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$38	Subscribers	2004	Code of Business Conduct and Ethics	Neurogen Corp.
$45	Subscribers Preview	2005	Employment Agreement	Neurogen Corp.
$35	Subscribers Preview	2006	Employment Agreement	Neurogen Corp.
$37	Subscribers Preview	2007	Employment Agreement	Neurogen Corp.
$42	Subscribers Preview	2007	Employment Agreement	Neurogen Corp.
$38	Subscribers Preview	2004	For Immediate Release	Neurogen Corp.	Pfizer, Inc.
$99	Subscribers Preview	2003	Lease	Cerebrus Limited; Marion Merrel Limited; Abbott Labs	Akzo Nobel 2 3 4 5 6
$37	Subscribers Preview	2004	Merck Announces Full-Year 2003 Earnings per Share (EPS) from Continuing Operations of $2.92, Fourth-Quarter 2003 EPS of 62 Cents	Medco Health; Merck	Neurogen; Schering-Plough
$41	Subscribers Preview	2003	Merck Strategy in Place to Deliver Long-Term Shareholder Value	Raymond V. Gilmartin; Merck	Neurogen; Schering-Plough
$38	Subscribers	2003	Neurogen and Merck Form Alliance to Develop Next-Generation Drugs for Pain and Other Disorders	Merck & Co., Inc.	Neurogen Corp.
$39	Subscribers Preview	2004	Non-Qualified Stock Option Agreement	Neurogen Corp.
$42	Subscribers Preview	2006	Placement Agency Agreement	Neurogen; CIBC World	Milbank Tweed
$31	Subscribers	2003	Press Release	Genentech; Neurogen; Protein Design	Seattle Genetics; Rice; Stanford
$41	Subscribers Preview	2003	Remarks of Raymond V. Gilmartin, Chairman, President, and Chief Executive Officer, Merck & Co., Inc. at the 2003 Annual Business Briefing	Merck & Co., Inc.	Neurogen Corp.
$56	Subscribers Preview	2004	Research Collaboration and License Agreement	Merck & Co., Inc.	Neurogen Corp.
$60	Subscribers Preview	2004	Securities Purchase Agreement	Merck; Neurogen; Pfizer	Milbank Tweed; Sullivan; Willkie Farr
$40	Subscribers Preview	2004	Securities Purchase Agreement	Merck; Neurogen; Pfizer	Warburg Pincus Private Equity VIII L P 2 3
$72	Subscribers Preview	2000	Statement of Additional Information	Amgen; Illinois Tool; Nationwide Life	Neurogen 2 3 4 2 2
$43	Subscribers Preview	2004	Stock Purchase Agreement	Merck; Neurogen	Milbank Tweed